Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 163INDUSTRY 61NETWORK 26NIH 23OTHER_GOV 3INDIV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Neutropenia 1Neoplasms 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Proflavine 9pembrolizumab 2Tacrolimus 2Pyridostigmine Bromide 2Prednisone 2Microbial Collagenase 2sargramostim 1plerixafor 1pegfilgrastim 1olaparib 1nilotinib 1macimorelin 1keyhole-limpet hemocyanin 1ethyl pyruvate 1compound W 1blinatumomab 1Watchful Waiting 1Uracil 1Tegafur 1Surgical Procedures, Operative 1Steroids 1Sodium Chloride 1Sirolimus 1Salicylates 1Peptides 1PM 01183 1Mycophenolic Acid 1Monatide (IMS 3015) 1Mifepristone 1Methylprednisolone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDIV × pegfilgrastim × Clear all
NCT00050674 2012-12-27

Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma

Schwartzberg, Lee, M.D.

Phase 2 Completed
40 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡